|
| 36256926 | The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. | Menopause | 2023 |
| 36219813 | The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort. | Menopause | 2022 |
| 33025002 | Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age. | American Journal of Epidemiology | 2021 |
| 33963837 | Physical Activity, Diet, and Incident Urinary Incontinence in Postmenopausal Women: Women's Health Initiative Observational Study. | | 2021 |
| 34313617 | Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS). | Menopause | 2021 |
| 32757806 | Reproductive history and osteoarthritis in the Women's Health Initiative. | Scand J Rheumatol | 2021 |
| 31326978 | Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women. | J Gerontol A Biol Sci Med Sci | 2020 |
| 32314786 | Prentice et al. Respond to "Studying Co-Occurrence of Multiple Outcomes". | American Journal of Epidemiology | 2020 |
| 32314781 | Dual-Outcome Intention-to-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials. | American Journal of Epidemiology | 2020 |
| 31624848 | Corrigendum to: Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women. | J Gerontol A Biol Sci Med Sci | 2020 |
| 32721007 | Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. | JAMA | 2020 |
| 31547915 | Associations of parental ages at childbirth with healthy aging among women. | | 2019 |
| 31542834 | Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study. | Cancer Causes Control | 2019 |
| 30871746 | Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women's Health Initiative). | Am J Cardiol | 2019 |
| 31023762 | Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA. | BMJ Open | 2019 |
| 29112594 | Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials. | Menopause | 2018 |
| 30124748 | Parental longevity predicts healthy ageing among women. | Age and Ageing | 2018 |
| 27854529 | Maternal Age at Childbirth and Parity as Predictors of Longevity Among Women in the United States: The Women's Health Initiative. | Am J Public Health | 2017 |
| 27465713 | Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative. | Menopause | 2017 |
| 28285070 | Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women. | Am J Med | 2017 |
| 26577506 | Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial. | Clin Lung Cancer | 2016 |
| 27197275 | Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 27433859 | Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative. | Menopause | 2016 |
| 26908437 | Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational Study. | Cancer Epidemiol Biomarkers Prev | 2016 |
| 26768386 | Military Generation and Its Relationship to Mortality in Women Veterans in the Women's Health Initiative. | Gerontologist | 2016 |
| 26220418 | Vasomotor Symptoms and Quality of Life Among Veteran and Non-Veteran Postmenopausal Women. | Gerontologist, The | 2016 |
| 26035151 | NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older. | Menopause | 2015 |
| 25534916 | Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). | Cancer Causes Control | 2015 |
| 25314150 | Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society. | Menopause | 2015 |
| 25349960 | Baseline age and time to major fracture in younger postmenopausal women. | Menopause | 2015 |
| 26382314 | Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey. | Menopause | 2015 |
| 25093722 | The North American Menopause Society at 25 years: celebrating our history and looking to the future. | Menopause | 2014 |
| 25322268 | Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative. | J Clin Endocrinol Metab | 2014 |
| 24217806 | Obesity and late-age survival without major disease or disability in older women. | JAMA Intern Med | 2014 |
| 24431262 | Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative. | J Bone Miner Res | 2014 |
| 24670297 | Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. | Breast Cancer Res | 2014 |
| 25160739 | Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. | Menopause | 2014 |
| 25155380 | Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. | Journal of Sexual Medicine | 2014 |
| 25140698 | Why the product labeling for low-dose vaginal estrogen should be changed. | Menopause | 2014 |
| 25225714 | The North American Menopause Society recommendations for clinical care of midlife women. | Menopause | 2014 |
| 25179577 | Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. | | 2014 |
| 25153131 | Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. | Climacteric | 2014 |
| 23497918 | Global Consensus Statement on menopausal hormone therapy. | Maturitas | 2013 |
| 24084921 | Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. | JAMA | 2013 |
| 23488524 | Global consensus statement on menopausal hormone therapy. | Climacteric | 2013 |
| 23615653 | In reply. | Menopause | 2013 |
| 23333549 | Relationship between hysterectomy and admixture in African American women. | Am J Obstet Gynecol | 2013 |
| 23652034 | Clinical Corner: a new feature in Menopause. | Menopause | 2013 |
| 22776849 | A decade after the Women's Health Initiative--the experts do agree. | Menopause | 2012 |
| 22401913 | Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. | Lancet Oncol | 2012 |